BIO
BIO
NYSE · Life Sciences Tools & Services

Bio-Rad Laboratories-A

$342.20
-5.66 (-1.63%)
Financial Highlights (FY 2026)
Revenue
2.54B
Net Income
747.92M
Gross Margin
52.0%
Profit Margin
29.4%
Rev Growth
-2.7%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 52.0% 52.0% 34.0% 34.0%
Operating Margin 1.6% 1.4% 7.9% 9.4%
Profit Margin 29.4% 28.0% 8.4% 9.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.54B 2.61B 3.74B 3.63B
Gross Profit 1.32B 1.36B 1.27B 1.24B
Operating Income 40.43M 37.38M 295.48M 340.82M
Net Income 747.92M 691.66M 316.01M 332.31M
Gross Margin 52.0% 52.0% 34.0% 34.0%
Operating Margin 1.6% 1.4% 7.9% 9.4%
Profit Margin 29.4% 28.0% 8.4% 9.2%
Rev Growth -2.7% -2.7% +9.0% +2.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 607.26M 607.26M 3.59B 2.84B
Total Equity 3.76B 3.76B 4.06B 4.19B
D/E Ratio 0.16 0.16 0.89 0.68
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 40.55M 39.58M 492.25M 510.81M
Free Cash Flow 138.31M 190.89M